Cargando…

DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2

Small cell lung cancer (SCLC) is an aggressive malignancy characterized by early metastasis, rapid development of resistance to chemotherapy, and genetic instability. This study profiles DNA methylation in SCLC, patient-derived xenografts (PDXs) and cell lines at single nucleotide resolution. DNA me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poirier, John T., Gardner, Eric E., Connis, Nick, Moreira, Andre L., de Stanchina, Elisa, Hann, Christine L., Rudin, Charles M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564363/ https://www.ncbi.nlm.nih.gov/pubmed/25746006 http://dx.doi.org/10.1038/onc.2015.38

Ejemplares similares

Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
por: Mao, Ninghui, et al.
Publicado: (2021)

High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma
por: Raffeld, Mark, et al.
Publicado: (2020)

Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer’s disease
por: Ossenkoppele, Rik, et al.
Publicado: (2020)

Replication Stress Defines Distinct Molecular Subtypes Across Cancers
por: Takahashi, Nobuyuki, et al.
Publicado: (2022)

Distinct DNA methylation profiles in subtypes of orofacial cleft
por: Sharp, Gemma C., et al.
Publicado: (2017)

FGFR1 expression defines clinically distinct subtypes in pancreatic cancer
por: Haq, Farhan, et al.
Publicado: (2018)

Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes
por: Wu, Fan, et al.
Publicado: (2022)

EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma
por: Lucas, Calixto-Hope G., et al.
Publicado: (2021)

Erlotinib Inhibits Growth of a Patient-Derived Chordoma Xenograft
por: Siu, I-Mei, et al.
Publicado: (2013)

Distinct and separable roles for EZH2 in neurogenic astroglia
por: Hwang, William W, et al.
Publicado: (2014)

MMR Deficiency Defines Distinct Molecular Subtype of Breast Cancer with Histone Proteomic Networks
por: Hacking, Sean, et al.
Publicado: (2023)

Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes
por: Messier, Terri L., et al.
Publicado: (2016)

Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer
por: Zinn, Rebekah L, et al.
Publicado: (2013)

EZH2 alterations in follicular lymphoma: biological and clinical correlations
por: Huet, S, et al.
Publicado: (2017)

Gliomas display distinct sex-based differential methylation patterns based on molecular subtype
por: Johansen, Mette L, et al.
Publicado: (2020)

Specific Glioma Prognostic Subtype Distinctions Based on DNA Methylation Patterns
por: Chen, Xueran, et al.
Publicado: (2019)

Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases
por: Ostridge, Kristoffer, et al.
Publicado: (2016)

An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
por: Tekpli, Xavier, et al.
Publicado: (2019)

Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits
por: Zhu, Yinjie, et al.
Publicado: (2023)

UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2023)

The ezh2(sa1199) mutant zebrafish display no distinct phenotype
por: San, Bilge, et al.
Publicado: (2019)

Differential methylation relative to breast cancer subtype and matched normal tissue reveals distinct patterns
por: Bardowell, Sabrina A., et al.
Publicado: (2013)

The nucleosome unwrapping free energy landscape defines distinct regions of transcription factor accessibility and kinetics
por: Donovan, Benjamin T, et al.
Publicado: (2023)

Histone Methylations Define Neural Stem/Progenitor Cell Subtypes in the Mouse Subventricular Zone
por: Zhang, Zhichao, et al.
Publicado: (2019)

Specific breast cancer prognosis‐subtype distinctions based on DNA methylation patterns
por: Zhang, Shumei, et al.
Publicado: (2018)

A DNA methylation‐based definition of biologically distinct breast cancer subtypes
por: Stefansson, Olafur A., et al.
Publicado: (2014)

Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis
por: Schneeberger, Valentina E., et al.
Publicado: (2016)

Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator
por: Kim, Jung, et al.
Publicado: (2018)

Loss of BAP1 function leads to EZH2-dependent transformation
por: LaFave, Lindsay M., et al.
Publicado: (2015)

Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations
por: Aoki, Kazunori, et al.
Publicado: (2023)

DNA methylation patterns–based subtype distinction and identification of soft tissue sarcoma prognosis
por: Li, Kai, et al.
Publicado: (2021)

DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features
por: Jian, Jimo, et al.
Publicado: (2023)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
por: Wu, Shi-yi, et al.
Publicado: (2022)

A distinct metabolic response characterizes sensitivity to EZH2 inhibition in multiple myeloma
por: Nylund, Patrick, et al.
Publicado: (2021)

DLPFC transcriptome defines two molecular subtypes of schizophrenia
por: Bowen, Elijah F. W., et al.
Publicado: (2019)

Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
por: Hirukawa, Alison, et al.
Publicado: (2018)

EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
por: Yoo, Kyung Hyun, et al.
Publicado: (2011)

EZH2 Exacerbates Breast Cancer by Methylating and Activating STAT3 Directly
por: Zhao, Yi, et al.
Publicado: (2021)

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma
por: Abou-Taleb, Hisham, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_emi273i621kpnrrt5upe6lkbp0